Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLFJOURNAL OF HEPATOLOGYIF332022-11-0148OA
Abnormal brain oxygen homeostasis in an animal model of liver diseaseJHEP REPORTSIF7.52022-08-0119OAAI
Hyperammonaemia induces mitochondrial dysfunction and neuronal cell deathJHEP REPORTSIF7.52022-08-0123OAAI
The role of RIPK1 mediated cell death in acute on chronic liver failure (vol 13, 416, 2022)CELL DEATH & DISEASEIF9.62022-04-292OAAI
The role of RIPK1 mediated cell death in acute on chronic liver failureCELL DEATH & DISEASEIF9.62021-12-1726OAAI
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failureJOURNAL OF HEPATOLOGYIF332020-07-01120OAAI
Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver FailureSCIENTIFIC REPORTSIF3.92020-01-1537OAAI
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver DiseaseHEPATOLOGYIF15.82019-10-1568OAAI
Non-canonical Inflammasome as a Driver of Hepatic Encephalopathy in a Mouse Model of Acute-on-Chronic Liver FailureAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62019-09-010PREAI
Inhibition of alpha 2A adrenergic receptors reduces liver inflammation in experimental NASHJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Targeting Toll-Like Receptor 4 signalling with TAK-242: A novel therapy for acute liver failureJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Inhibition of toll-like receptor 4 using TAK-242 is a novel therapy for prevention and treatment of acute-on-chronic liver failureJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Impaired brain glymphatic flow in experimental hepatic encephalopathy (vol 69, pg 40, 2019)JOURNAL OF HEPATOLOGYIF332019-03-010PREAI
Impaired brain glymphatic flow in experimental hepatic encephalopathyJOURNAL OF HEPATOLOGYIF332019-01-0160OAAI
Acute-on-chronic liver failure is characterised by hepatocyte gasdermin D cleavage and release of the pro-inflammatory Damage Associated Molecular Pattern (DAMP) IL-αJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Treatment with the Adra2a antagonist, Yohimbine, reduces fibrosis progression and liver inflammation in a NASH fibrosis ratJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Brain glymphatic clearance is impaired in a rat model of cirrhosisJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
Neurobehavioral disturbances and hyperammonemia are evident in rodent model of NAFLD prior to cirrhosis stagesJOURNAL OF HEPATOLOGYIF332017-01-011PREAI
Systemic delivery of gene therapy - a proof of concept study in a model of cirrhosis and portal hypertensionJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向